Pharmacological Reviews Get Tables of Contents delivered automatically
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wurtman, R. J.
Right arrow Articles by Melamed, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wurtman, R. J.
Right arrow Articles by Melamed, E.

Pharmacological Reviews, Vol 32, 315-335, Copyright © 1980 by American Society for Pharmacology and Experimental Therapeutics

Precursor control of neurotransmitter synthesis

RJ Wurtman, F Hefti and E Melamed

Studies performed during the past decade have shown that the rates at which certain neurons produce and release their neurotransmitters can be affected by precursor availability, and thus by the changes in plasma composition that occur after ingestion of the precursors in purified form or as constituents of foods. Thus, tryptophan administration or a plasma ratio of tryptophan to other large neutral amino acids, thereby raising brain tryptophan levels, increasing the substrate saturation of tryptophan hydroxylase, and accelerating the synthesis and release of serotonin. Tyrosine administration or a high- protein meal similarly elevates brain tyrosine and can accelerate catecholamine synthesis in the CNS and sympathoadrenal cells, while the consumption of lecithin or choline increases brain choline levels and neuronal acetylcholine synthesis. The physiologic and biochemical mechanisms that must exist in order for nutrient consumption to affect neurotransmitte synthesis have been characterized and include: 1) the lack of significant feedback control of plasma levels of the precursor; 2) the lack of a real "bloodbrain barrier" for the precursor, i.e. the ability of the plasma level of the precursor to control its influx into, or efflux from, the CNS; 3) the existence of a low-affinity (and thus unsaturated) transport system mediating the flux of the precursor between blood and brain; 4) low-affinity kinetics for the enzyme that initiates the conversion of the precursor to the transmitter; and, 5) the lack of end-product inhibition of the enzyme, in vivo, by its ultimate product, the neurotransmitter. The extent to which neurotransmitter synthesis in any particular aminergic neuron happens to be affected by changes in the availability of its precursor probably varies directly with the neuron's firing frequency. This relationship allows precursor administration to produce selective physiologic effects by enhancing neurotransmitter release from some but not all of the neurons potentially capable of utilizing the precursor for this purpose. It also allows the investigator to predict when administering the precursor might be useful for amplifying a physiologic process, or for treating a pathologic state. (for example, tyrosine administration raises blood pressure in hypotensive rats, lowers it in hypertensive animals, and has little effect on blood pressure in normotensive animals; the elevation in blood pressure probably reflects enhanced catecholamine release from sympathoadrenal cells, while the reduction in hypertensive animals probably results from increased catecholamine release within the brain-stem.) Such predictions are now being tested clinically in many institution. Available evidence suggests that lecithin or cholie administration can diminish the frequency of abnormal movements in patients with tardive dyskinesia...


This article has been cited by other articles:


Home page
FASEB J.Home page
L. Wang, T. J. Maher, and R. J. Wurtman
Oral L-glutamine increases GABA levels in striatal tissue and extracellular fluid
FASEB J, April 1, 2007; 21(4): 1227 - 1232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Aziz, G. H. Anderson, A. Giacca, and F. Cho
Hyperglycemia after protein ingestion concurrent with injection of a GLP-1 receptor agonist in rats: a possible role for dietary peptides
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R688 - R694.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. J Wurtman, J. J Wurtman, M. M Regan, J. M McDermott, R. H Tsay, and J. J Breu
Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios
Am. J. Clinical Nutrition, January 1, 2003; 77(1): 128 - 132.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. N. Young
Clinical nutrition: 3. The fuzzy boundary between nutrition and psychopharmacology
Can. Med. Assoc. J., January 1, 2002; 166(2): 205 - 209.
[Full Text]


Home page
ScienceHome page
R. J. Davidson, K. M. Putnam, and C. L. Larson
Dysfunction in the Neural Circuitry of Emotion Regulation--A Possible Prelude to Violence
Science, July 28, 2000; 289(5479): 591 - 594.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
J. D Fernstrom
Can nutrient supplements modify brain function?
Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1669S - 1673.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. C. van der Mast, W. W. van den Broek, D. Fekkes, L. Pepplinkhuizen, and J. D. F. Habbema
Is Delirium After Cardiac Surgery Related to Plasma Amino Acids and Physical Condition?
J Neuropsychiatry Clin Neurosci, February 1, 2000; 12(1): 57 - 63.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Köppen, J. Klein, C. Erb, and K. Löffelholz
Acetylcholine Release and Choline Availability in Rat Hippocampus: Effects of Exogenous Choline and Nicotinamide
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1139 - 1145.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Nishizawa, C. Benkelfat, S. N. Young, M. Leyton, S. Mzengeza, C. de Montigny, P. Blier, and M. Diksic
Differences between males and females in rates of serotonin synthesis in human brain
PNAS, May 13, 1997; 94(10): 5308 - 5313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition